The RACE for children act at one year: progress in pediatric development of molecularly targeted oncology drugs.

Published in: Expert review of anticancer therapy (2022)

Early evidence suggests that the RACE Act was effective at closing the loopholes of previous legislation and creating new opportunities for innovation in developing therapies for childhood cancers.

Keyphrases

childhood cancer
young adults
palliative care
cancer therapy
early life
drug induced